San Jose, CA, United States of America

Christopher Bergey


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2017-2021

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Christopher Bergey: Innovator in Optical Technology

Introduction

Christopher Bergey is a notable inventor based in San Jose, CA (US). He has made significant contributions to the field of optical technology, holding a total of 5 patents. His work focuses on enhancing communication systems through innovative methods and systems.

Latest Patents

Bergey's latest patents include a method and system for a bi-directional multi-wavelength receiver for standard single-mode fiber based on grating couplers. This invention involves an integrated circuit that incorporates a multi-wavelength grating coupler and first and second optical sources. The system is designed to receive optical data signals at different wavelengths, facilitating efficient communication through optical fibers. The technology aims to improve the performance of optoelectronic transceivers by enabling the communication of multiple optical data signals simultaneously.

Career Highlights

Christopher Bergey is currently employed at Luxtera, Inc., where he continues to develop cutting-edge optical technologies. His expertise in the field has led to advancements that are crucial for modern communication systems. His innovative approach has positioned him as a key player in the industry.

Collaborations

Bergey has collaborated with talented individuals such as Peter DeDobbelaere and Attila Mekis. These partnerships have fostered a creative environment that encourages the development of groundbreaking technologies.

Conclusion

Christopher Bergey is a prominent inventor whose work in optical technology has made a significant impact on communication systems. His patents reflect his commitment to innovation and excellence in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…